# ACTHar in the Treatment of Lupus Nephritis

> **NCT02226341** · PHASE4 · TERMINATED · sponsor: **Columbia University** · enrollment: 8 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** CellCept
- **DRUG:** ACTHar gel

## Key facts

- **NCT ID:** NCT02226341
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2024-01-03
- **Final completion:** 2024-01-03
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02226341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02226341, "ACTHar in the Treatment of Lupus Nephritis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02226341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*